Please complete the form here or contact [email protected] to learn more about licensing content from the Endocrine Society.

If you believe you should have access to this media, please login.

Classic Therapies for Fatty Liver Disease: Evidence for Some Oldie but Goodie Therapies

Presentations in This Video

What is in the name and why it matters - non alcoholic fatty liver disease vs metabolic dysfunction associated fatty liver disease?

Amalia -- Gastaldelli, PhD

Institute of Clinical Physiology CNR Pisa

Incretin and SGLT2 inhibitor therapy for metabolic dysfunction-associated steatotic liver disease

Philip -- Newsome, MD, PhD

University of Birmingham

Classic therapies for fatty liver disease: Evidence for some oldie but goodie therapies

Aman -- Rajpal, MD, DABOM

Alameda Health System

Chair

Minna -- Woo, MD, PhD

University of Toronto

Related Media